Top compounds associated with response to ARL3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 9e-07
mRNA PD318088 CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.17 1e-06
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 3e-06
mRNA Erlotinib CCLE pan-cancer AAC -0.22 3e-06
mRNA PD-0325901 CCLE pan-cancer AAC -0.21 3e-06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.18 6e-06
mRNA AZD6244 CCLE pan-cancer AAC -0.19 3e-05
Download CSV